Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles - PubMed (original) (raw)
. 1998 Jan 14;242(2):357-64.
doi: 10.1006/bbrc.1997.7913.
Affiliations
- PMID: 9446799
- DOI: 10.1006/bbrc.1997.7913
Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles
N Kuroyanagi et al. Biochem Biophys Res Commun. 1998.
Abstract
SR-protein-specific kinase 1 (SRPK1) is first identified as a specific kinase for SR splicing factors. By RT-PCR of a conserved kinase domain, novel SR-protein-specific kinase clones were isolated from mouse brain. The cloned cDNAs encode a 106 kDa protein (648 amino acids, 92% identical to human SRPK1) and a 120 kDa protein (681 amino acids, 58% identical to human SRPK1). Therefore, they were designated mSRPK1 and mSRPK2, respectively. Northern blotting revealed the ubiquitous expression of mSRPK1 in all tissues examined and the tissue-specific expression of mSRPK2 in testis, lung, and brain. Both kinases phosphorylated SF2/ASF, a member of SR proteins in vitro and the phosphopeptide mappings were identical, indicating that these kinases phosphorylate the same site of SF2/ASF. Overexpression of mSRPK2 caused disassembly of cotransfected SF2/ASF and endogenous SC35. Our results indicate that SRPK family members may regulate the disassembly of the SR proteins in a tissue-specific manner.
Similar articles
- The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
Colwill K, Pawson T, Andrews B, Prasad J, Manley JL, Bell JC, Duncan PI. Colwill K, et al. EMBO J. 1996 Jan 15;15(2):265-75. EMBO J. 1996. PMID: 8617202 Free PMC article. - Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B, Allemand E, Facompré M, Bailly C, Riou JF, Soret J, Tazi J. Pilch B, et al. Cancer Res. 2001 Sep 15;61(18):6876-84. Cancer Res. 2001. PMID: 11559564 - Serine-arginine protein kinases: new players in neurodegenerative diseases?
Chan CB, Ye K. Chan CB, et al. Rev Neurosci. 2013;24(4):401-13. doi: 10.1515/revneuro-2013-0014. Rev Neurosci. 2013. PMID: 23828492 Review. - Good Cop, Bad Cop: The Different Roles of SRPKs.
Nikolakaki E, Sigala I, Giannakouros T. Nikolakaki E, et al. Front Genet. 2022 Jun 2;13:902718. doi: 10.3389/fgene.2022.902718. eCollection 2022. Front Genet. 2022. PMID: 35719374 Free PMC article. Review.
Cited by
- The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations.
Malakar P, Shukla S, Mondal M, Kar RK, Siddiqui JA. Malakar P, et al. RNA Biol. 2024 Jan;21(1):1-20. doi: 10.1080/15476286.2023.2286099. Epub 2023 Nov 28. RNA Biol. 2024. PMID: 38017665 Free PMC article. Review. - Functions of SRPK, CLK and DYRK kinases in stem cells, development, and human developmental disorders.
Hogg EKJ, Findlay GM. Hogg EKJ, et al. FEBS Lett. 2023 Oct;597(19):2375-2415. doi: 10.1002/1873-3468.14723. Epub 2023 Sep 4. FEBS Lett. 2023. PMID: 37607329 Free PMC article. Review. - Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities.
Araki S, Ohori M, Yugami M. Araki S, et al. Front Oncol. 2023 Jun 5;13:1152087. doi: 10.3389/fonc.2023.1152087. eCollection 2023. Front Oncol. 2023. PMID: 37342192 Free PMC article. Review. - Serine-arginine protein kinases and their targets in viral infection and their inhibition.
Zheng K, Ren Z, Wang Y. Zheng K, et al. Cell Mol Life Sci. 2023 May 17;80(6):153. doi: 10.1007/s00018-023-04808-6. Cell Mol Life Sci. 2023. PMID: 37198350 Free PMC article. Review. - SRPKs: a promising therapeutic target in cancer.
Tufail M, Wu C. Tufail M, et al. Clin Exp Med. 2023 Nov;23(7):3093-3112. doi: 10.1007/s10238-023-01054-9. Epub 2023 Apr 7. Clin Exp Med. 2023. PMID: 37027068 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials